Shenzhen Gatecore Biotech Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenzhen Gatecore Biotech Co., Ltd. - overview
Established
2023
Location
Shenzhen, Guangdong, China
Primary Industry
Biotechnology
About
Based in Shenzhen, China and founded in 2023, Shenzhen Gatecore Biotech Co. , Ltd. , develops semiconductor-enabled proteomics detection technologies for the biotechnology and medical research sectors. The company was established at the intersection of biology and semiconductors to address unmet needs in ultra-sensitive protein analysis and scalable immunodetection.
The company works with research institutions, biotech firms, and diagnostics developers to provide ultra-sensitive single-molecule immunodetection platforms and related proteomics technologies. Its semiconductor-driven systems enable fast, high-throughput, and low-cost protein detection for applications such as early disease screening, biomarker discovery, and precision diagnostics. The company generates revenue by supplying its detection platforms and associated technology solutions to research, diagnostics, and biotech customers. In December 2025, Shenzhen Gatecore Biotech Co.
, Ltd. closed Series A funding from new investors Shenzhen Capital Real Estate Fund, Shenzhen Nanshan Huirong Investment and Taiyou Fund.
Current Investors
Taiyou Fund, Shenzhen Capital Real Estate Fund, Shenzhen Nanshan Huirong Investment
Primary Industry
Biotechnology
Sub Industries
Biotechnology, Healthcare, Semiconductors
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.